Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) high institutional ownership speaks...

Published on 8 Jan 2025 on Simply Wall St. · via Yahoo Finance

Key Insights Given the large stake in the stock by institutions, Atara Biotherapeutics' stock price...

Read the rest of the article

Start tracking your investments with Statfolio

Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several...

Zacks · via Yahoo Finance 8 Jan 2025

Key Insights Given the large stake in the stock by institutions, Atara Biotherapeutics' stock pri...

Simply Wall St. · via Yahoo Finance 8 Jan 2025

Key Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have s...

Simply Wall St. via Yahoo Finance 31 Jan 2024

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has de...

GuruFocus.com via Yahoo Finance 14 Jan 2024

In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed ...

Insider Monkey via Yahoo Finance 22 Nov 2023

Atara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapie...

Zacks · via Yahoo Finance 14 Nov 2023

Now Read This: Disney, US Foods And 3 Stocks To Watch Heading Into Thursday

Benzinga 9 Nov 2023

Atara Biotherapeutics, Inc. ATRA shares are trading lower after the company said that primary ana...

Benzinga 9 Nov 2023

U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Follow...

Benzinga 9 Nov 2023

Investing.com 8 Nov 2023